EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieVergleichsstudieOpen Access · CC BY-NC-ND 4.0

Prognostic impact of switching to the 2021 chronic kidney disease epidemiology collaboration creatinine-based equation in Caucasian patients with type 2 diabetes: the Renal Insufficiency and Cardiovascular events (RIACE) Italian Multicenter Study

Monia Garofolo, Martina Vitale, Giuseppe Penno, Anna Solini, Emanuela Orsi, Valeria Grancini, Enzo Bonora, Cecilia Fondelli, Roberto Trevisan, Monica Vedovato, Antonio Nicolucci, Giuseppe Pugliese und 1 weitere

Cardiovascular Diabetology · 2024

DOI: 10.1186/s12933-024-02450-5 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cardiovascular Diabetology, 2024. Verfasst von Monia Garofolo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fondazione Diabete Ricerca, Diabetes, Endocrinology and Metabolism Foundation, Eli Lilly.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: A Chronic Kidney Disease (CKD) Epidemiology Collaboration (EPI) formula not including a Black race coefficient has been recently developed and is now recommended in the US. The new (2021) equation was shown to yield higher estimated glomerular filtration rate (eGFR) values than the old (2009) one in a non-Black general population sample, thus reclassifying a significant number of individuals to a better eGFR category. However, reclassified individuals were previously shown to have a lower risk of progression to end-stage kidney disease, but higher adjusted risks for all-cause death and morbidity and mortality from cardiovascular disease than those not reclassified. This study evaluated the prognostic impact of switching from the 2009 to the 2021 CKD-EPI equation in non-Black individuals with type 2 diabetes. METHODS: The Renal Insufficiency And Cardiovascular Events (RIACE) was a prospective cohort study enrolling 15,773 Caucasian patients in 19 Italian centers in 2006-2008. Cardiometabolic risk profile, treatments, complications, and comorbidities were assessed at baseline and eGFR was calculated with the two equations. Vital status was retrieved on 31 October 2015 for 15,656 participants (99.3%). RESULTS: With the 2021 equation, the eGFR value increased in all patients, except for 293 individuals with a 2009 eGFR ≥ 105 ml·min- 1·1.73 m- 2. The median difference was 4.10 ml·min- 1·1.73 m- 2 and was higher in males, older individuals and those in the G2 category. Reclassification decreased the percentage of patients with reduced eGFR from 17.28 to 13.96% and with any CKD from 36.23 to 34.03%. Reclassified individuals had better cardiometabolic risk profile and lower prevalence of complications and use of medications than non-reclassified individuals. Risk of death versus the 2009 G1 category was lower for reclassified than non-reclassified participants in all eGFR categories and, particularly, in each 2009 eGFR category, though difference was significant only in the G4-G5 category. The Receiver Operator Characteristic curves were statistically, but not clinically different with the two equations. CONCLUSION: Changing from the 2009 to the 2021 CKD-EPI equation results in higher eGFR and lower CKD prevalence, with a lower risk of death in reclassified patients with an eGFR < 30 ml·min- 1·1.73 m- 2, but virtually no impact on mortality prediction. TRIAL REGISTRATION: ClinicalTrials.gov, NCT00715481, retrospectively registered 15 July, 2008.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesDiabetes Mellitus, Type 2Diabetic NephropathiesRenal Insufficiency, ChronicAgedFemaleHumansMaleMiddle AgedBiomarkersCreatinineDecision Support TechniquesGlomerular Filtration RateItalyKidneyModels, BiologicalPredictive Value of TestsPrognosisProspective StudiesRace FactorsRisk AssessmentRisk FactorsTime FactorsWhite People

Stichwörter der Autor:innen

All-cause mortalityChronic kidney disease epidemiology collaboration equationEstimated glomerular filtration rateRaceType 2 diabetes

Substanzen

BiomarkersCreatinine

Autor:innen und Institutionen

  • Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Department of Clinical and Molecular Medicine, "La Sapienza" University, Via di Grottarossa, Rome, 1035-1039 - 00189, Italy.
  • Department of Surgical, Medical, Molecular and Critical Area Pathology, University of Pisa, Pisa, Italy.
  • Diabetes Unit, Fondazione IRCCS "Cà Granda - Ospedale Maggiore Policlinico", Milan, Italy.
  • Division of Endocrinology, Diabetes and Metabolism, University and Hospital Trust of Verona, Verona, Italy.
  • Diabetes Unit, University of Siena, Siena, Italy.

Förderung

  • Fondazione Diabete Ricerca
  • Diabetes, Endocrinology and Metabolism Foundation
  • Eli Lilly
  • Sigma-Tau Pharmaceuticals
  • Boehringer Ingelheim
  • Chiesi Farmaceutici
  • Takeda Pharmaceutical Company

Zitieren

APA

Garofolo, M., Vitale, M., Penno, G., Solini, A., Orsi, E., Grancini, V., Bonora, E., Fondelli, C., Trevisan, R., Vedovato, M., Nicolucci, A., Pugliese, G., & Renal Insufficiency And Cardiovascular Events (RIACE) Study Group (2024). Prognostic impact of switching to the 2021 chronic kidney disease epidemiology collaboration creatinine-based equation in Caucasian patients with type 2 diabetes: the Renal Insufficiency and Cardiovascular events (RIACE) Italian Multicenter Study. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-024-02450-5

Vancouver

Garofolo M, Vitale M, Penno G, Solini A, Orsi E, Grancini V, et al. Prognostic impact of switching to the 2021 chronic kidney disease epidemiology collaboration creatinine-based equation in Caucasian patients with type 2 diabetes: the Renal Insufficiency and Cardiovascular events (RIACE) Italian Multicenter Study. Cardiovascular Diabetology. 2024. doi:10.1186/s12933-024-02450-5

BibTeX
@article{Garofolo2024,
  author = {Garofolo, Monia and Vitale, Martina and Penno, Giuseppe and Solini, Anna and Orsi, Emanuela and Grancini, Valeria and Bonora, Enzo and Fondelli, Cecilia and Trevisan, Roberto and Vedovato, Monica and Nicolucci, Antonio and Pugliese, Giuseppe and Renal Insufficiency And Cardiovascular Events (RIACE) Study Group, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group},
  title = {Prognostic impact of switching to the 2021 chronic kidney disease epidemiology collaboration creatinine-based equation in Caucasian patients with type 2 diabetes: the Renal Insufficiency and Cardiovascular events (RIACE) Italian Multicenter Study},
  journal = {Cardiovascular Diabetology},
  year = {2024},
  doi = {10.1186/s12933-024-02450-5}
}
Kostenlos starten →